Inventor · disambiguated record
Miriam Kidron
Also filed as: KIDRON MIRIAM
16 granted patents·17 pending applications·341 citations·filing 1984–2025
94Inventor score
Top patents by PatentIndex Score
33 records- 0196US11395848B2Methods and compositions for treating diabetesORAMED LTD·Filed 2020·Granted Jul 26, 2022·4 cites·20 claims
- 0296US9186412B2Methods and compositions for oral administration of insulinKIDRON MIRIAM·Filed 2009·Granted Nov 17, 2015·49 cites·21 claims
- 0393US10010503B2Methods and compositions for oral administrationENTERA BIO LTD·Filed 2015·Granted Jul 3, 2018·11 cites·24 claims
- 0492US11660327B2Methods and compositions for oral administration of proteinsORAMED LTD·Filed 2020·Granted May 30, 2023·2 cites·1 claims
- 0592US9259456B2Methods and compositions for oral administration of proteinsKIDRON MIRIAM·Filed 2006·Granted Feb 16, 2016·19 cites·45 claims
- 0691US10967051B2Methods and compositions for treating NAFLD, hepatic steatosis, and sequelae thereofORAMED LTD·Filed 2018·Granted Apr 6, 2021·3 cites·19 claims
- 0791US10881714B2Methods and compositions for oral administration of proteinsORAMED LTD·Filed 2018·Granted Jan 5, 2021·4 cites·29 claims
- 0891US4579730APharmaceutical compositions containing insulinHADASSAH MED ORG·Filed 1984·Granted Apr 1, 1986·212 cites·4 claims
- 0990US10420721B2Methods and compositions for oral administrationENTERA BIO LTD·Filed 2018·Granted Sep 24, 2019·6 cites·16 claims
- 1090US10058593B2Methods and compositions for oral administration of proteinsKIDRON MIRIAM·Filed 2009·Granted Aug 28, 2018·7 cites·46 claims
- 1187US10398762B2Methods and compositions for treating diabetesORAMED LTD·Filed 2013·Granted Sep 3, 2019·7 cites·23 claims
- 1286US11246827B2Methods and compositions for oral administrationENTERA BIO LTD·Filed 2019·Granted Feb 15, 2022·1 cites·16 claims
- 1386US10933022B2Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using sameORAMED LTD·Filed 2019·Granted Mar 2, 2021·3 cites·26 claims
- 1485US10350162B2Methods and compositions for oral administration of exenatideORAMED LTD·Filed 2013·Granted Jul 16, 2019·6 cites·11 claims
- 1585US2024299503A1Methods and Compositions for Treating DiabetesORAMED LTD·Filed 2023·Application pending·0 cites
- 1685US2025281579A1Methods and Compositions for Oral Administration of ProteinsORAMED PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1783US2025281396A1Methods and compositions for oral administrationENTERA BIO LTD·Filed 2025·Application pending·0 cites
- 1882US10342764B2Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using sameORAMED LTD·Filed 2013·Granted Jul 9, 2019·7 cites·46 claims
- 1982US2024181018A1Methods and Compositions for Treating NAFLD, Hepatic Steatosis, and Sequelae ThereofORAMED LTD·Filed 2023·Application pending·0 cites
- 2080US12311051B2Methods and compositions for oral administrationENTERA BIO LTD·Filed 2022·Granted May 27, 2025·0 cites·16 claims
- 2180US2023210956A1Methods and compositions for treating diabetesORAMED LTD·Filed 2022·Application pending·0 cites
- 2278US2024358647A1Protease Inhibitor-Containing Compositions, Compositions Comprising Same, and Methods for Producing and Using SameORAMED LTD·Filed 2023·Application pending·0 cites
- 2376US2025387453A1Methods and Compositions for Treating DiabetesORAMED LTD·Filed 2025·Application pending·0 cites
- 2474US2022160839A1Methods and compositions for oral administration of proteinsORAMED PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2571US2022000986A1Methods and Compositions for Treating NAFLD, Hepatic Steatosis, and Sequelae ThereofORAMED LTD·Filed 2021·Application pending·0 cites
- 2671US2021322305A1Methods and Compositions for Oral Administration of ExenatideORAMED LTD·Filed 2021·Application pending·0 cites
- 2767US2019374615A1Methods and Compositions for Treating DiabetesORAMED LTD·Filed 2019·Application pending·0 cites
- 2866US2021369626A1Protease Inhibitor-Containing Compositions, Compositions Comprising Same, and Methods for Producing and Using SameORAMED LTD·Filed 2021·Application pending·0 cites
- 2966US2011046053A1Methods and compositions for oral administration of exenatideORAMED LTD·Filed 2009·Application pending·0 cites
- 3062US2019314275A1Methods and Compositions for Rectal Administration of ExenatideORAMED LTD·Filed 2019·Application pending·0 cites
- 3160US2015335715A1Methods and compositions for treating nafld, hepatic steatosis, and sequelae thereofORAMED LTD·Filed 2014·Application pending·0 cites
- 3253US2016206703A1Methods and compositions for oral administration of proteinsORAMED PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3339US2021244806A1Recombinant Protease Inhibitor-Containing Compositions, Methods for Producing Same and Uses ThereofORAMED LTD·Filed 2019·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →